Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry
vs
history
Cash to Debt No Debt
CCEL's Cash to Debt is ranked higher than
100% of the 240 Companies
in the Global Medical Care industry.

( Industry Median: 0.23 vs. CCEL: No Debt )
CCEL' s 10-Year Cash to Debt Range
Min: 0.17   Max: No Debt
Current: No Debt

Equity to Asset -0.95
CCEL's Equity to Asset is ranked lower than
56% of the 232 Companies
in the Global Medical Care industry.

( Industry Median: 0.45 vs. CCEL: -0.95 )
CCEL' s 10-Year Equity to Asset Range
Min: -0.95   Max: 0.92
Current: -0.95

-0.95
0.92
Interest Coverage 1.22
CCEL's Interest Coverage is ranked higher than
51% of the 154 Companies
in the Global Medical Care industry.

( Industry Median: 5.49 vs. CCEL: 1.22 )
CCEL' s 10-Year Interest Coverage Range
Min: 1.22   Max: 9999.99
Current: 1.22

1.22
9999.99
F-Score: 7
Z-Score: -2.07
M-Score: -2.05
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 6/10

vs
industry
vs
history
Operating margin (%) 8.97
CCEL's Operating margin (%) is ranked higher than
75% of the 234 Companies
in the Global Medical Care industry.

( Industry Median: 9.44 vs. CCEL: 8.97 )
CCEL' s 10-Year Operating margin (%) Range
Min: -440   Max: 29.63
Current: 8.97

-440
29.63
Net-margin (%) 0.14
CCEL's Net-margin (%) is ranked higher than
62% of the 234 Companies
in the Global Medical Care industry.

( Industry Median: 4.97 vs. CCEL: 0.14 )
CCEL' s 10-Year Net-margin (%) Range
Min: -460   Max: 23.26
Current: 0.14

-460
23.26
ROA (%) 0.23
CCEL's ROA (%) is ranked higher than
62% of the 235 Companies
in the Global Medical Care industry.

( Industry Median: 3.63 vs. CCEL: 0.23 )
CCEL' s 10-Year ROA (%) Range
Min: -104.23   Max: 24.1
Current: 0.23

-104.23
24.1
ROC (Joel Greenblatt) (%) 141.09
CCEL's ROC (Joel Greenblatt) (%) is ranked higher than
97% of the 233 Companies
in the Global Medical Care industry.

( Industry Median: 16.84 vs. CCEL: 141.09 )
CCEL' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -500.44   Max: 150.54
Current: 141.09

-500.44
150.54
Revenue Growth (%) 4.90
CCEL's Revenue Growth (%) is ranked higher than
71% of the 200 Companies
in the Global Medical Care industry.

( Industry Median: 7.00 vs. CCEL: 4.90 )
CCEL' s 10-Year Revenue Growth (%) Range
Min: -17.9   Max: 96.4
Current: 4.9

-17.9
96.4
EBITDA Growth (%) -18.30
CCEL's EBITDA Growth (%) is ranked higher than
56% of the 171 Companies
in the Global Medical Care industry.

( Industry Median: 6.80 vs. CCEL: -18.30 )
CCEL' s 10-Year EBITDA Growth (%) Range
Min: 0   Max: 59.9
Current: -18.3

0
59.9
EPS Growth (%) -100.00
CCEL's EPS Growth (%) is ranked lower than
52% of the 153 Companies
in the Global Medical Care industry.

( Industry Median: 10.90 vs. CCEL: -100.00 )
CCEL' s 10-Year EPS Growth (%) Range
Min: -100   Max: 96.4
Current: -100

-100
96.4
» CCEL's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Insider Trades

Latest Guru Trades with CCEL



No Insider Trades Found!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 37.40
CCEL's P/E(ttm) is ranked higher than
74% of the 258 Companies
in the Global Medical Care industry.

( Industry Median: 39.10 vs. CCEL: 37.40 )
CCEL' s 10-Year P/E(ttm) Range
Min: 3.88   Max: 520
Current: 37.4

3.88
520
P/S 1.43
CCEL's P/S is ranked higher than
73% of the 258 Companies
in the Global Medical Care industry.

( Industry Median: 1.64 vs. CCEL: 1.43 )
CCEL' s 10-Year P/S Range
Min: 0.28   Max: 5.1
Current: 1.43

0.28
5.1
EV-to-EBIT 9.12
CCEL's EV-to-EBIT is ranked higher than
97% of the 258 Companies
in the Global Medical Care industry.

( Industry Median: 26.54 vs. CCEL: 9.12 )
CCEL' s 10-Year EV-to-EBIT Range
Min: 0.5   Max: 162.7
Current: 9.12

0.5
162.7
Current Ratio 0.96
CCEL's Current Ratio is ranked higher than
63% of the 236 Companies
in the Global Medical Care industry.

( Industry Median: 1.40 vs. CCEL: 0.96 )
CCEL' s 10-Year Current Ratio Range
Min: 0.47   Max: 35.3
Current: 0.96

0.47
35.3
Quick Ratio 0.96
CCEL's Quick Ratio is ranked higher than
64% of the 236 Companies
in the Global Medical Care industry.

( Industry Median: 1.24 vs. CCEL: 0.96 )
CCEL' s 10-Year Quick Ratio Range
Min: 0.47   Max: 35.3
Current: 0.96

0.47
35.3

Valuation & Return

vs
industry
vs
history
Price/Median PS Value 1.00
CCEL's Price/Median PS Value is ranked higher than
82% of the 258 Companies
in the Global Medical Care industry.

( Industry Median: 1.27 vs. CCEL: 1.00 )
CCEL' s 10-Year Price/Median PS Value Range
Min: 0.3   Max: 84.38
Current: 1

0.3
84.38
Earnings Yield (Greenblatt) 11.70
CCEL's Earnings Yield (Greenblatt) is ranked higher than
92% of the 225 Companies
in the Global Medical Care industry.

( Industry Median: 5.40 vs. CCEL: 11.70 )
CCEL' s 10-Year Earnings Yield (Greenblatt) Range
Min: 0.6   Max: 211.1
Current: 11.7

0.6
211.1
Forward Rate of Return (Yacktman) 3.49
CCEL's Forward Rate of Return (Yacktman) is ranked higher than
67% of the 203 Companies
in the Global Medical Care industry.

( Industry Median: 10.68 vs. CCEL: 3.49 )
CCEL' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -3.8   Max: 4.9
Current: 3.49

-3.8
4.9

Business Description

Industry: Health Care Providers » Medical Care
Compare:CHE, FMS, DVA, FSNUY, BDUUF » details
Cryo-Cell International, Inc. was incorporated on September 11, 1989 in the State of Delaware. The Company is engaged in cellular processing and cryogenic storage, with a current focus on the collection and preservation of umbilical cord (U-Cord9(r)) blood stem cells for family use. The Company has established private family cord blood stem cell banks in terms of the number of specimens preserved. Its headquarters facility in Oldsmar, Florida handles all aspects of its U.S.-based business operations, including the processing and storage of specimens. The specimens are stored in commercially available cryogenic storage units at the Company's technologically and operationally advanced facility in Oldsmar, Florida. It has expanded its research and development activities to develop technologies related to stem cells other than umbilical cord blood stem cells. During 2006, in parallel with its R&D associated with placental stem cells, the Company discovered novel technology related to menstrual stem cells. In November 2007, the Company announced the launch of its C'elleSM service related to this patent-pending technology, and the Company continues to focus its current research and development activities mainly on the C'elle service and related new menstrual stem cell technologies. The Company is actively marketing the C'elle service both through a bundled offer with the Company's U-Cord service and on a stand-alone basis. The Company markets its cord blood stem cell preservation services directly to expectant parents and by distributing information through obstetricians, pediatricians, Lamaze instructors and other childbirth educators, certified nurse-midwives and other related healthcare professionals. To increase awareness among expectant parent audiences, the Company continues to promote its service in several national targeted prenatal magazines including American Baby and Fit Pregnancy, as well as several magazines distributed during childbirth classes. Expectant parents have also received information via emails and the Company has increased its internet marketing campaigns. Its competitors are Cord Blood Registry, Inc., ViaCord, a division of ViaCell, Inc., a wholly-owned subsidiary of PerkinElmer and LifeBankUSA, a division of Celgene. The Company is required to register with the FDA under the Public Health Service Act.
» More Articles for CCEL

Headlines

Articles On GuruFocus.com

More From Other Websites
CRYO CELL INTERNATIONAL INC Financials Jul 11 2014
CRYO CELL INTERNATIONAL INC Files SEC form 8-K, Results of Operations and Financial Condition,... Jul 08 2014
Cryo-Cell Reports Second Quarter 2014 Results Jul 07 2014
CRYO CELL INTERNATIONAL INC Files SEC form 10-Q, Quarterly Report Jul 03 2014
CRYO CELL INTERNATIONAL INC Files SEC form 8-K, Change in Directors or Principal Officers May 15 2014
CRYO CELL INTERNATIONAL INC Files SEC form 8-K, Results of Operations and Financial Condition,... Apr 15 2014
CRYO CELL INTERNATIONAL INC Files SEC form 10-Q, Quarterly Report Apr 14 2014
CRYO CELL INTERNATIONAL INC Files SEC form 8-K, Results of Operations and Financial Condition,... Mar 04 2014
CRYO CELL INTERNATIONAL INC Files SEC form 10-K, Annual Report Feb 28 2014
CRYO CELL INTERNATIONAL INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial... Feb 27 2014
CRYO CELL INTERNATIONAL INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Nov 22 2013
CRYO CELL INTERNATIONAL INC Files SEC form 8-K, Change in Directors or Principal Officers Oct 30 2013
CRYO CELL INTERNATIONAL INC Files SEC form 8-K, Results of Operations and Financial Condition,... Oct 16 2013
CRYO CELL INTERNATIONAL INC Files SEC form 10-Q, Quarterly Report Oct 15 2013
CRYO CELL INTERNATIONAL INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders,... Jul 23 2013
CRYO CELL INTERNATIONAL INC Files SEC form 8-K, Results of Operations and Financial Condition,... Jul 15 2013

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Add Notes, Comments or Ask Questions

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide